Navigation Links
Varian Medical Systems Schedules Investor Meeting at ASTRO in San Francisco
Date:8/11/2014

PALO ALTO, Calif., Aug. 11, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will hold a meeting for investors on Tuesday, September 16, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco.

Varian will host a meeting with management, beginning with breakfast at 7:30 a.m. and webcast presentations from 8:00 a.m. to 10:00 a.m. on Tuesday at the San Francisco Marriott Marquis, 780 Mission Street, in the Nob Hill meeting room.  Presentations by leading clinicians and Varian managers will focus on clinical needs in radiation oncology and how they are being addressed.

To RSVP for the meeting , click on: http://varian.investorroom.com/ASTRO , or contact Anne Rambo at (650) 424-5834, or by e-mail: anne.rambo@varian.com.  Please RSVP by Tuesday, September 9, 2014. 

The meeting and presentation will be webcast beginning at 8:00 a.m. Pacific Time.  To access the webcast, click on http://investors.varian.com/index.php?s=19&item=253.

To reserve a hotel room in San Francisco and to register for additional ASTRO seminars, please visit the ASTRO web site at www.astro.org or call (800) 541-6058.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes and digital detectors, for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 6,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit http://www.varian.com or follow us on Twitter.

FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Announces Acquisition of Certain Assets of Transpire, Inc., a Specialized Developer of Radiation Simulation Software
2. Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland
3. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014
4. CIVCO to Showcase Protura and Varian Interface at AAPM 2014
5. Varian to Highlight Software that Augments Quality Assurance Processes in Radiation Oncology at the 2014 American Association of Physicists in Medicine (AAPM) Meeting
6. Varian Medical Systems Holds Developer Workshop for Researchers Working on Next Generation Technologies in Radiation Oncology
7. Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator
8. CRLX101 Meets Primary Endpoint in Phase 2 Clinical Trial in Relapsed Ovarian Cancer
9. Varian Medical Systems Publishes 2013 Annual Report on Investor Web Site
10. Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluges Successor
11. Varian Medical Systems Schedules First Quarter FY2014 News Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that its Board of Directors has approved ... the third quarter of 2017. ... paid on or about October 27, 2017 to stockholders of ... 2017.  Future declarations of dividends are subject to approval of ...
Breaking Medicine Technology:
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry ... educational webinar, they will present the line of epMotion automated liquid handling system. ... you can automate everyday pipetting tasks. , Ideal for scientists and lab technicians ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston area ... Texas, is launching a regional charity effort to provide publicity assistance and generate ... Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that has ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... Boca Raton (PRWEB) , ... August 18, 2017 , ... ... is continuing to ramp up its marketing efforts with its product now available through ... hangover remedy to the public. The effervescent powdered drink is designed to quickly detox ...
Breaking Medicine News(10 mins):